To the Editor: Psychiatric comorbidities are known to impair adherence to highly active antiretroviral therapy (HAART) in human immunodeficiency virus (HIV)-infected individuals 1 and to affect women and men differently.
alcohol, 9 reported side effects, 10 and were employed were more likely to be nonadherent to HAART. Such factors have been commonly found as determinants of nonadherence to HAART in several contexts, particularly in disadvantaged populations whose adherence may be compromised by socioeconomic barriers and psychiatric comorbidities. 11 Interestingly, anxiety symptoms remained associated with nonadherence to HAART in men who had (OR [95% CI] = 1.5 [1.1-2.1]) and had not (OR [95% CI] = 1.5 [1.2-2.0]) received anxiolytics, while women with anxiety symptoms who had received anxiolytics exhibited the same adherence as women with no anxiety symptoms. To test whether these results were attributable to the limited sample size of women, we performed a sensitivity analysis in men using a series of reduced samples (n = 446) and computed OR estimations by bootstrap. 12 This approach confirmed the results that were found in the whole male sample.
Co-occurring anxiety disorders are more frequently associated with major depression in women. 13 Moreover, women are more sensitive than men to the pathogenic effects of low levels of social support at the onset of major depression, 14 and it is possible that the social impact of HIV may contribute further to the onset of psychiatric disorders. Confirming results from a previous study, 15 we found that women with alcohol abuse have a higher risk of nonadherence to HAART, and there is a significant linear trend (P < 10 
